the aid library

Filter

318

Safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

World Health Organization WHO (2021) C_WHO

COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn ... more

Malawi: Assessment of the Logistics and Supply Chain Management of Anti-TB Medicines

Chana, R USAID (2009) C1

What are relevant, feasible and effective approaches to promote acceptance, uptake and adherence to physical distancing measures for COVID-19 prevention and control?

Ryan, R.E.; et al. World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Health Evidence Network synthesis report 72

Philippines: Drug Price Reference List
recommended

Anna Melissa S. Guerrero Department of Health (DOH) (2015) C1

Glossary of terms used in Pharmacovigilance

World Health Organization (WHO) (2011) C_WHO

A double dose of inequality; Pharma companies and the Covid-19 vaccines crisis

Amnesty International (2022) C2

22 Sept. 2021 The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi ... more

Safe Management of Wastes from Health-Care Activities, 2nd. ed.
recommended

World Health Organization WHO (2014) C_WHO

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1

Research Monograph of the Updated 2010-2016 Philippine Plan of Action to Control Tuberculosis

National TB Control Program, Department of Health (2014) C1

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol

European Centre for Disease Prevention and Control ECDC (2020) CC

This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th ... more

Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination

World Health Organization WHO (2022) C_WHO

Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method ... more

Evaluation of drug promotional materials in a hospital setting in Nepal

Alam K., Shah A.K., Ojah P., et al. Southern Med Review (2009) C1

Southern Med Review (2009)2;1:2-6

Fair global distribution of COVID-19 vaccines
recommended

Reijer, P.; and S. Mauder (2021) CC

MEDBOX Issue Brief no.9 ,1 Febr. 2021

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis

Pantelias, A.; King, J.D.; Lammie, P.; Weil, G.J. The American Journal of Tropical Medicine and Hygiene (2022) CC

Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO ... more

Expanding sustainable vaccine manufacturing in Africa: Priorities for Support

GAVI Alliance (2022) C1

Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future ... more

WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicine
recommended

World Health Organization WHO (2007) C_WHO

The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.

WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems

World Health Organization WHO (2015) C_WHO

This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin ... more

Integrated Community Case Management of Childhood Illness

USAID; MCHIP (2014) CC

Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal SUMMARY REPORT Accessed at March 2014

GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI

Pharmacy, Medicines & Poisons Board (PMPB), Malawi (2015) C2

PMPB/INS-GUIDE/02